Skip to main content
Top

2006 | OriginalPaper | Hoofdstuk

Kan norfloxacine congenitale afwijkingen veroorzaken?

Auteur : W.E. Reuvers-Lodewijks

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Norfloxacine (Noroxin®) is een gefluorideerde chinolonverbinding. Het bactericide-effect berust op beïnvloeding van de DNA-synthese door remming van het bacteriële DNA-gyrase. Het brede werkingsspectrum van de chinolonen omvat bijna alle Gramnegatieve en een aantal Gram-positieve bacteriën.
Literatuur
go back to reference Corrado ML, et al. Review of safetystudies. Am J Med 1987; 82: 22-26. Corrado ML, et al. Review of safetystudies. Am J Med 1987; 82: 22-26.
go back to reference Gough AW, et al. Quinolone arthropathy-acute toxicity to immature cartilage. Toxicology 1992; 20: 436-50. Gough AW, et al. Quinolone arthropathy-acute toxicity to immature cartilage. Toxicology 1992; 20: 436-50.
go back to reference Stahlmann R, Förtser C, Sickle D van. Quinolones in children. Drug Saf 1993; 9: 397-403. Stahlmann R, Förtser C, Sickle D van. Quinolones in children. Drug Saf 1993; 9: 397-403.
go back to reference Pino A, Maura A, Villa F, Masciangelo L. Evaluation of DNA damage induced by norfloxacin in liver and kidney of adult rats and in fetal tissues after transplacental exposure. Mutat Res 1991; 264: 81-85. Pino A, Maura A, Villa F, Masciangelo L. Evaluation of DNA damage induced by norfloxacin in liver and kidney of adult rats and in fetal tissues after transplacental exposure. Mutat Res 1991; 264: 81-85.
go back to reference Ikura T, et al. In: Shepard TH. Catalog of Teratogenic Agents, 4th ed. Baltimore: John Hopkins University Press, 1986: 423-24. Ikura T, et al. In: Shepard TH. Catalog of Teratogenic Agents, 4th ed. Baltimore: John Hopkins University Press, 1986: 423-24.
go back to reference Cukierski MA, et al. Embryotoxicity studies of norfloxacin in Cynomegalusmonkeys: I Teratology studies and norfloxacin plasmaconcentration in pregnant and nonpregnant monkeys. Teratology 1989; 39: 39-52. Cukierski MA, et al. Embryotoxicity studies of norfloxacin in Cynomegalusmonkeys: I Teratology studies and norfloxacin plasmaconcentration in pregnant and nonpregnant monkeys. Teratology 1989; 39: 39-52.
go back to reference Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 535-38. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 535-38.
go back to reference Andreou R, Schick B, Sage S, Cook l, Donnefeld A, Koren G. New postmarketing surveillance data supports a lack of association between quino lone use in pregnancy and fetal and neonatal complications. Reprod Toxicol 1991; 9: 584. Andreou R, Schick B, Sage S, Cook l, Donnefeld A, Koren G. New postmarketing surveillance data supports a lack of association between quino lone use in pregnancy and fetal and neonatal complications. Reprod Toxicol 1991; 9: 584.
go back to reference Schaefer C, et al (ENTIS). Pregnancy outcome after prenatal exposure. Europ J Obstet Gynec 1996; 69: 83-89. Schaefer C, et al (ENTIS). Pregnancy outcome after prenatal exposure. Europ J Obstet Gynec 1996; 69: 83-89.
Metagegevens
Titel
Kan norfloxacine congenitale afwijkingen veroorzaken?
Auteur
W.E. Reuvers-Lodewijks
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_694